PubMed

Monitoring cholesterol levels: measurement error or true change?

Glasziou PP, Irwig L, Heritier S, Simes RJ, Tonkin A; LIPID Study Investigators.

Ann Intern Med. 2008 May 6;148(9):656-61.PMID: 18458278 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators.

Stewart RA, Sharples KJ, North FM, Menkes DB, Baker J, Simes J.

Arch Intern Med. 2000 Nov 13;160(20):3144-52.PMID: 11074745 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).

Tonkin AM.

Am J Cardiol. 1995 Sep 28;76(9):107C-112C.PMID: 7572678 [PubMed - indexed for MEDLINE]Related articles

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

Glasziou PP, Eckermann SD, Mulray SE, Simes RJ, Martin AJ, Kirby AC, Hall JP, Caleo S, White HD, Tonkin AM.

Med J Aust. 2002 Oct 21;177(8):428-34.PMID: 12381252 [PubMed - indexed for MEDLINE]Related articlesFree article

Design, rational, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project--a combined analysis of three large-scale randomized trials: Long-term Intervention with Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS).

[No authors listed]

Am J Cardiol. 1995 Nov 1;76(12):899-905.PMID: 7484829 [PubMed - indexed for MEDLINE]Related articles

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Rahman M, Baimbridge C, Davis BR, Barzilay J, Basile JN, Henriquez MA, Huml A, Kopyt N, Louis GT, Pressel SL, Rosendorff C, Sastrasinh S, Stanford C; ALLHAT Collaborative Research Group.

Am J Kidney Dis. 2008 Sep;52(3):412-24. Epub 2008 Aug 3.PMID: 18676075 [PubMed - indexed for MEDLINE]Related articles

Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris.

[No authors listed]

Am J Cardiol. 1995 Sep 1;76(7):474-9.PMID: 7653447 [PubMed - indexed for MEDLINE]Related articles

[Clinical study of the month. The LIPID study: "long-term intervention with pravastatin in ischaemic disease"]

Scheen AJ.

Rev Med Liege. 1999 Jan;54(1):2-3. French. PMID: 10081301 [PubMed - indexed for MEDLINE]Related articles

Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin.

West MJ, White HD, Simes RJ, Kirby A, Watson JD, Anderson NE, Hankey GJ, Wonders S, Hunt D, Tonkin AM.

J Hypertens. 2002 Dec;20(12):2513-7.PMID: 12473877 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.

Tonkin AM, Eckermann S, White H, Friedlander D, Glasziou P, Magnus P, Kirby A, Mulray S, Denton M, Sallaberger M, Hunt D, Simes J; LIPID Study Group.

Am Heart J. 2006 Jun;151(6):1305-12.PMID: 16781242 [PubMed - indexed for MEDLINE]Related articles

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E; PROVE IT-TIMI 22 Investigators.

J Am Coll Cardiol. 2008 Feb 19;51(7):724-30.PMID: 18279736 [PubMed - indexed for MEDLINE]Related articles

Lipid Re-screening: What Is the Best Measure and Interval?

Takahashi O, Glasziou PP, Perera R, Shimbo T, Suwa J, Hiramatsu S, Fukui T.

Heart. 2009 Jun 14. [Epub ahead of print]PMID: 19528038 [PubMed - as supplied by publisher]Related articles

Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.

Nestel PJ, Baghurst K, Colquhoun DM, Simes RJ, Mehalski K, White HD, Tonkin AM, Kirby A, Pollicino C; Long-Term Intervention with Pravastatin in Ischaemic Disease Study Investigators.

Am J Clin Nutr. 2005 Jun;81(6):1322-9.PMID: 15941882 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study.

Nakagawa T, Kobayashi T, Awata N, Sato S, Reiber JH, Nakajima H, Toyama YN, Hiraoka H, Kato O, Kirino M, Kobayashi T, Takeda Y, Yachiku K, Iida M, Itoh T, Shibata N.

Int J Cardiol. 2004 Oct;97(1):107-14.PMID: 15336816 [PubMed - indexed for MEDLINE]Related articles

Lipid levels after acute coronary syndromes.

Pitt B, Loscalzo J, Ycas J, Raichlen JS.

J Am Coll Cardiol. 2008 Apr 15;51(15):1440-5.PMID: 18402897 [PubMed - indexed for MEDLINE]Related articles

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.

Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y; MEGA Study Group.

Lancet. 2006 Sep 30;368(9542):1155-63.PMID: 17011942 [PubMed - indexed for MEDLINE]Related articles

Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.

Stewart RA, North FM, Sharples KJ, Simes RJ, Tonkin AM, White HD; Long-term Intervention with Pravastatin in Ischaemic Disease Study Investigators.

N Z Med J. 2008 Feb 15;121(1269):11-23.PMID: 18278078 [PubMed - indexed for MEDLINE]Related articles

Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.

van der Harst P, Asselbergs FW, Hillege HL, Bakker SJ, Voors AA, van Veldhuisen DJ, van Gilst WH; PREVEND-IT Investigators.

Am J Cardiol. 2007 Nov 15;100(10):1548-51.PMID: 17996517 [PubMed - indexed for MEDLINE]Related articles

Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.

Hedman M, Miettinen TA, Gylling H, Ketomäki A, Antikainen M.

J Pediatr. 2006 Feb;148(2):241-6.PMID: 16492436 [PubMed - indexed for MEDLINE]Related articles

Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment.

Takeshita M, Katsuragi Y, Kusuhara M, Higashi K, Miyajima E, Mizuno K, Mori K, Obata T, Ohmori R, Ohsuzu F, Onodera Y, Sano J, Sawada S, Tabata S, Tokimitsu I, Tomonobu K, Yamashita T, Yasukawa T, Yonemura A, Nakamura H.

Nutr Metab Cardiovasc Dis. 2008 Sep;18(7):483-91. Epub 2007 Oct 26.PMID: 17964767 [PubMed - indexed for MEDLINE]Related articles